Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656745 · ClinicalTrials.gov registry record · NA
Clinical Trial of Smoking Cessation Mobile Phone Program
A NA study, sponsored by Click Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
NCT02656745: Completed NA study, sponsored by Click Therapeutics.
NCT02656745 is a NA study that has completed, run by Click Therapeutics. The registered enrollment target is 416 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02656745, a NA study, has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
Study Summary
The Sponsor is doing a research study to assess the effects of a smartphone program designed to help users smoke less and eventually quit. When participants join, their involvement in the core study will last 8 weeks. After 8 weeks, they will have the option to continue using the program to guide their quit journey or participate in follow-up research.
Primary Outcome
The primary objective is to assess the proportion of the Intent to Treat population who remain active users of the program at the end of the 8 week primary study period. Active use is defined as the manipulation of at least one component of the application per week.
Interventions
- DEVICE Mobile Smoking Cessation Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02656745 record still lists
NCT02656745 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile Smoking Cessation Solution is the first listed.
NCT02656745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02656745 about?
NCT02656745 is a clinical study titled "Clinical Trial of Smoking Cessation Mobile Phone Program". The Sponsor is doing a research study to assess the effects of a smartphone program designed to help users smoke less and eventually quit. When participants join, their involvement in the core study will last 8 weeks. After 8 weeks, they will have the option to continue using the program to guide th...
What is the current status of trial NCT02656745?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2016-05. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02656745?
The interventions under investigation include: Mobile Smoking Cessation Solution (DEVICE).
Who is sponsoring clinical trial NCT02656745?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02656745's enrollment target sits among peer trials
416 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia